Navigation Links
Synteract to Host Joint Statistical Meeting Roundtable in San Diego
Date:7/24/2012

SAN DIEGO, July 24, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will host the roundtable, "Beyond number-crunching and data-monitoring: challenging roles for CRO statisticians," at the Joint Statistical Meetings (JSM), on  August 1, 2012 at 12:30 p.m., PDT. The roundtable will be moderated by Jia Hu, biostatistician II, from Synteract. JSM is the largest gathering of statisticians held in North America, attended by more than 6,000 people. JSM 2012 will be held in San Diego at the San Diego Convention Center July 28 – August 2.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

The roundtable is aligned with the company's Shared Work – Shared Vision approach to doing business, furthering collaboration with clients to support their Phase I-IV clinical development objectives. Roundtable highlights include:

  • How CRO statisticians can impact the speed and efficiency of clinical trials by providing feedback on study rationale, design and procedures
  • Why it is beneficial for CRO statisticians to provide comprehensive clinical analysis
  • Insights into the collaborative model for doing clinical research and why it is essential to successful study conduct as competition increases in the clinical trial arena
  • Discussion of the challenges facing CRO statisticians to remain proactive and collaborative as drug development grows in complexity and sponsor demands increase to keep pace
  • How biostatistics teams can adjust to new strategic roles beyond traditional passive data analysis and monitoring

JSM is held jointly with the American Statistical Association, the International Biometric Society (ENAR and WNAR), the Institute of Mathematical Statistics, the Statistical Society of Canada, the International Chinese Statistical Association, and the International Indian Statistical Association. The conference has sold out this year; however, for more information on attending or registering for next year, visit the JSM website or contact meetings@amstat.org.

The JSM roundtable is another opportunity for Synteract to share its expertise and thought leadership on topics relevant to the industry and its client base.  The company unveiled its new branding at DIA 2012 to highlight its partnership approach and full-range of Phase I-IV services and will be hosting a CDISC workshop at its North Carolina office in August. The company is also hiring and plans to augment the already notable breadth of expertise it offers biotechnology, medical device, and pharmaceutical companies.

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Synteract
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
2. MARC travel award announced for the 2012 ASCI/AAP Joint Meeting
3. Discovered a new checkpoint of cell cycle control through joint action of 2 proteins
4. US research vessel winds down visit to Vietnam as part of joint oceanographic research program
5. A new application allows online statistical analysis of gene-expression data
6. Bed bugs, stink bugs headline Entomology Meeting in Hartford, Conn.
7. GSA North-Central Section Meeting: Change through Time
8. Registration open for the Ecological Society of Americas 2012 Annual Meeting in Portland, Ore.
9. 2012 ARVO Award recipients honored at annual meeting
10. Second Middle East & Africa Osteoporosis Meeting to take place in Jordan
11. DOE Plasma Science Center Annual Meeting at Princeton Plasma Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: